1.The Haplotype Analyses Using Multiple Markers of the Apolipoprotein B Gene in Patients with Coronary Artery Disease.
Seung Ho HONG ; Junghan SONG ; Jin Q KIM
Journal of Korean Medical Science 2001;16(6):719-724
The high level of low density lipoprotein (LDL) is a risk factor for cardiovascular disease. Apolipoprotein (apo) B is a major protein component of LDL and plays an important role in the maintenance of cholesterol homeostasis. In this study, six polymorphic sites of the apoB gene were anlaysed in 235 patients with coronary artery disease (CAD) and 216 normal control subjects. There were no significant differences in the allele frequencies of apoB polymorphisms between the control and patient groups. However, haplotype frequencies were significantly different between the CAD patients and control (p<0.05). In addition, the allelic distributions of both EcoRI and MspI polymorphisms in Koreans were similar to those in Chinese but significantly different from those in Caucasians. ApoB polymorphisms showed no association with plasma lipid levels. In conclusion, haplotype analysis of the apoB gene using multiple diallelic markers might be a useful marker for Korean CAD patients.
Adult
;
Apolipoproteins B/*genetics
;
Coronary Arteriosclerosis/*genetics
;
Female
;
Gene Frequency
;
Genetic Markers
;
Haplotypes
;
Human
;
Korea
;
Male
;
Middle Age
;
Polymorphism (Genetics)
;
Variation (Genetics)
2.Effect of chronic enhanced external counterpulastion on gene expression profiles of arterial endothelial cells of pigs fed with high-cholesterol diet.
Xiao-hong HE ; Gui-fu WU ; Yan ZHANG ; Xiao-lin CHEN ; Zhen-sheng ZHANG ; Cheng-yang ZHAN ; Jun LIU ; Jian-gui HE ; Yan XIONG ; Dian-qiu FANG ; Lu-guang LIANG ; Yue-tao QIAN ; Gui-fang LIN ; Gang DAI ; Ming-zhe FENG ; Kui-jian WANG ; Zhen-yu ZHU ; Hong MA
Journal of Southern Medical University 2008;28(7):1195-1197
OBJECTIVETo investigate the effect of chronic enhanced external counterpulastion (EECP) on gene expression profiles of arterial endothelial cells (ECs) of pigs fed with high-cholesterol diet.
METHODSEight male pigs were fed with high-cholesterol diet for 12 weeks to induce arteriosclerosis and subjected to EECP for accumulative 36 h (2 h every other day for 18 sessions). Another 8 pigs on cholesterol-enriched diet and 6 normally fed pigs served as the arteriosclerosis model group and normal control group, respectively, and the high-cholesterol diet was maintained until the end of EECP treatment. The coronary artery was then isolated for transmission electro microscopy, and the abdominal aorta was observed using Sudan III staining. The gene expression profiles in ECs from the thoracic aorta using cDNA microarrays.
RESULTSMacrophages and foam cells were detected beneath the ECs in the coronary artery of pigs in the model group, but not in the other two groups. The ratios of Sudan III-positive area in the celiac aorta were significantly lower in normal control and EECP groups than in the model control group (P<0.05). Compared with the normal control group, the gene expressions of integrins-beta1 and CTGF were up-regulated in the model group. Compared with the model group, the expressions of integrins-beta1, CTGF and VCAM-1 were down-regulated and eNOS up-regulated in EECP group.
CONCLUSIONChronic EECP may reduce endothelial injury, down-regulate the gene expression level of integrin-beta1, CTGF and VCAM-1, lower cholesterol uptake and attenuate arterial endothelial inflammation to protect the pigs fed with high-cholesterol diet from arteriosclerosis.
Animals ; Aorta, Abdominal ; metabolism ; pathology ; Arteriosclerosis ; etiology ; genetics ; pathology ; Coronary Vessels ; metabolism ; pathology ; Counterpulsation ; methods ; Diet, Atherogenic ; Endothelial Cells ; metabolism ; Gene Expression Profiling ; Male ; Oligonucleotide Array Sequence Analysis ; methods ; Swine
3.Association of the Gene Polymorphisms of Platelet Glycoprotein Ia and IIb/IIIa with Myocardial Infarction and Extent of Coronary Artery Disease in the Korean Population.
Sungha PARK ; Hyun Young PARK ; Chanmi PARK ; Young Guk KO ; Eun Kyung IM ; Inho JO ; Chol SHIN ; Jong Bok LEE ; Won Heum SHIM ; Seung Yun CHO ; Yangsoo JANG
Yonsei Medical Journal 2004;45(3):428-434
Platelet membrane receptor glycoproteins (GP) are essential for the platelet activation process, and the genetic polymorphisms in the genes that encode platelet glycoproteins have been proposed to influence the risk of acute coronary syndrome and atherosclerosis. In this study, we investigated the role of GPIa, HPA-1 and HPA-3 polymorphisms as putative risk factors for myocardial infarction (MI) and the extent of coronary artery disease. We selected 1, 073 subjects who underwent coronary angiography; 242 had normal or minimal coronary atherosclerosis, and 831 patients had significant coronary artery disease (CAD). The genotype was determined by the methods of single base extension for C807T/G873A polymorphisms of GPIa, and restriction fragment length polymorphism for HPA-1 and HPA-3. The C807T and G873A polymorphisms of GPIa showed complete linkage in the Korean population. For HPA-1 gene polymorphism, only the HPA-1a/a (PlA1/A1) genotype was observed in 192 selected subjects from our study population. The distribution of GPIa (C807T/G873A) and HPA-3 genotypes did not differ significantly between normal subjects and CAD subjects. No significant association between MI and both gene polymorphisms was present. However, for the subgroup analysis of young male patients whose age was less than 56 years, the genotype frequency of HPA-3b/b was significantly lower in patients with MI compared to patients without a history of MI (7.5% vs. 20.0%, p=0.04). The odds ratio for HPA-3 b homozygosity versus the HPA-3a carrier was 0.32 (95% CI, 0.10- 0.99, p=0.04). Conclusively, HPA-3 polymorphism was associated with MI in Korean individuals younger than 56 years of age, but other polymorphisms of GP, which we studied, were not associated with both the extent of coronary atherosclerosis or MI.
Aged
;
Coronary Arteriosclerosis/epidemiology/*genetics
;
Female
;
Gene Frequency
;
Genetic Predisposition to Disease/epidemiology
;
Genotype
;
Human
;
Integrin alpha2/*genetics
;
Integrin beta3/*genetics
;
Korea
;
Male
;
Middle Aged
;
Myocardial Infarction/epidemiology/*genetics
;
Platelet Membrane Glycoprotein IIb/*genetics
;
*Polymorphism (Genetics)
;
Risk Factors
;
Support, Non-U.S. Gov't
4.Polymorphism of Matrix Metalloproteinase-3 Promoter Gene as a Risk Factor for Coronary Artery Lesions in Kawasaki Disease.
Jeong Ah PARK ; Kyung Sue SHIN ; Youn Woo KIM
Journal of Korean Medical Science 2005;20(4):607-611
Kawasaki disease (KD) is a major cause of acquired coronary artery diseases in childhood. The serum levels of matrix metalloproteinase (MMP)-3 and MMP-9 in KD have been reported to be significantly higher than other diseases. Several studies have demonstrated that MMP-3 5A/6A polymorphism and MMP-9 C-1562T polymorphism modify each transcriptional activity in allele specific manner. We hypothesized that these polymorphisms may play a role as a risk factor for development of coronary artery lesions (CAL) in KD. Eighty-three patients, diagnosed with KD in Cheju National University Hospital from January 2000 to February 2004, were divided into two groups according to the presence of CAL. Genotyping of MMP-3 and MMP-9 gene polymorphisms were determined by restriction fragment length polymorphism. With regard to MMP-3 gene polymorphism, the KD with CAL group had a higher frequency of 6A/6A genotype than control group (p=0.0127) and the KD without CAL group (p=0.0036). However, no significant differences in the allele and genotype distributions of the MMP-9 polymorphism were observed. These findings suggest that MMP-3 6A/6A genotype may be an independent risk factor for CAL formation in KD.
Adolescent
;
Adult
;
Aged
;
Alleles
;
Child
;
Child, Preschool
;
Coronary Arteriosclerosis/enzymology/etiology/*genetics
;
Female
;
Gelatinase B/genetics
;
Gene Frequency
;
Genotype
;
Humans
;
Infant
;
Male
;
Middle Aged
;
Mucocutaneous Lymph Node Syndrome/*complications
;
*Polymorphism, Genetic
;
Promoter Regions (Genetics)/*genetics
;
Research Support, Non-U.S. Gov't
;
Risk Factors
;
Stromelysin 1/*genetics